Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
20.36%Gross Profits to Assets
VS
Market
Sector
Industry
History
$ 0.8Close
$ 0.58 - $ 1.87 52-Week Range
Ticker Information
Ticker
CUECompany Name
CUE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCUE BIOPHARMA INC - Gross Profits to Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CUE - GPA Historical data
| Date | Total Assets | Gross Profit | Gross Profits to Assets |
|---|---|---|---|
| 6/30/2025 | $ 40.71M | $ 8.29M | 20.36% |
| 3/31/2025 | $ 22.25M | $ 7.99M | 35.91% |
| 12/31/2024 | $ 32.19M | $ 9.29M | 28.85% |
| 9/30/2024 | $ 44.81M | $ 9.53M | 21.27% |
| 6/30/2024 | $ 42.33M | $ 8.3M | 19.6% |
| 3/31/2024 | $ 53.95M | $ 7.02M | 13.01% |
| 12/31/2023 | $ 61.53M | $ 5.49M | 8.92% |
| 9/30/2023 | $ 68.89M | $ 3.82M | 5.55% |
| 6/30/2023 | $ 73.16M | $ 1.79M | 2.44% |
| 3/31/2023 | $ 81.68M | $ 432.23K | 0.53% |
Key Performance Insights, Last 5 Years
- CUE BIOPHARMA INC's latest trailing twelve months (TTM) GPA stands at 3.5%.
- Over the past 5 years, CUE BIOPHARMA INC's average GPA has been 12.19%.
- The median GPA for CUE BIOPHARMA INC during this period was 10.67%
- CUE BIOPHARMA INC reached its highest GPA over the past 5 years at 35.91%.
- The lowest GPA recorded by CUE BIOPHARMA INC in the same timeframe 0.53%
CUE BIOPHARMA INC's GPA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GPA Benchmarks
Similar metrics to GPA:
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Asset Turnover - [Calculation] The Asset Turnover ratio measures how effective a company uses its assets to generate revenue. It is calculated as [Revenue] divided by [Assets].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Gross Profit - [Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Definition of Gross Profits to Assets
[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].GP / Assets
(=) GPA GPA for CUE BIOPHARMA INC is calculated as follows: GP [ $ 3.73M ] / Assets [ $ 106.62M ]
(=) GPA [ 3.5% ] CUE - Gross Profits to Assets, Last 5 years
0.53%
Minimum
Mar 31, 2023
35.91%
Maximum
Mar 31, 2025
12.19%
Average
10.67%
Median
GPA Benchmark AnalysisMarket
The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.94%.
The following table provides additional summary stats:
GPA in the Market:
| filtered constituents | 4.13K |
|---|---|
| min | -50.32% |
| max | 83.98% |
| average | 20.16% |
| median | 15.35% |
| std | 19.94% |